You're going to hear a lot more about "ASA resistance"
You're going to hear a lot more about "ASA resistance." Now that millions of people take low-dose ASA to prevent cardiovascular disease, we're seeing that it doesn't always work.
About 10% of the population might be resistant to ASA's antiplatelet effects. These patients might be up to 3 times more likely to die of cardiovascular disease.
Two tests for ASA resistance are already on the market... AspirinCheck and AspirinWorks.